Fig. 1
From: RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma
Expression of RBIS in clinical lung cancer samples and its correlation with prognosis. A, B Expression of RBIS in different cancer types from the TIMER and ULCAN databases. C Expression of RBIS in the GSE102287, GSE30219 and ULCAN-TCGA datasets. D, E Expression of RBIS in different pathological stages and lymph node metastasis stages of LUAD in the ULCAN database. F Analysis of the correlation between the RBIS and the prognosis of lung adenocarcinoma patients using the Kaplan, GEPIA and TIMER databases. G mRNA expression of RBIS in 60 clinical lung cancer samples. H Statistical analysis revealed high expression of RBIS in 55.7% of the lung cancer tissues